Stemcell United Share Price and Company Fundamentals

0.001 (7.692%)
52 week
0.011 - 0.049

Last traded: Last Friday at 6:10 AM

Stemcell United Limited, together with its subsidiaries, engages in the sourcing, producing, marketing, and selling of traditional medicines in Australia, Singapore, Greater China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company has a collaboration agreement with Temasek Polytechnic of Singapore to conduct joint research on the application of plant stem cell technology to the cultivation and commercial farming of seagrapes in Singapore; collaboration with Yunnan Hongyi Agriculture Development Co Ltd; and collaboration agreement with the University of Science, Malaysia to study the cultivation of sea grapes through the use of land-based and urban farming techniques. The company was formerly known as On Q Group Limited and changed its name to Stemcell United Limited in September 2015. Stemcell United Limited was incorporated in 1984 and is headquartered in Sydney, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield



Market cap


Enterprise value


Company profile

Primary activitiesCommercialisation of dendrobium stem cell extraction
Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Mailing address126 Phillip Street Level 5 Sydney NSW 2000 Australia
Phone / Fax61 2 8072 1400 / 61 2 8072 1400


Stemcell United does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Stemcell United.

NameTitleAgeTotal Pay
Mr. Huan Qing GuCEO, MD & Director239.55k
Mr. Chow-Yee KohCFO & Director4490k
Ms. Elizabeth SpoonerCompany Sec.

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Stemcell United is 14.61M and its enterprise value is 11.25M. The enterprise value to revenue ratio of SCU is 1.33.

The SCU's stocks Beta value is 2.99 making it 199% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Stemcell United (SCU)

Stemcell United (ASX:SCU) Frequently Asked Questions

1. What is Stemcell United's Stock Symbol?

Stemcell United trades on ASX under the ticker symbol "SCU".

2. What is Stemcell United's stock price today?

One share of SCU stock can currently be purchased for approximately $0.014.

3. How can I contact Stemcell United?

Stemcell United's mailing address is 126 Phillip Street Level 5 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 8072 1400.

4. What is Stemcell United's official website?

The official website of Stemcell United is

5. Which share registry manages Stemcell United's stock?

Stemcell United's stock is managed by AUTOMIC REGISTRY SERVICES.